Pain and Supplements: How to Incorporate the Guidelines

Dietary supplements are a $30 billion industry with a significant portion of use secondary to pain and pain-related diagnoses. This session will review the prevalence of supplement use in specific pain conditions and important issues related to the topic including regulation and potential...

Pain and CAM: What do the Guidelines Say

Patient Risk Assessment by Interview

Current commonly used risk assessment measures are brief paper and pencil inventories to be completed by patients. These tools have limitations, however, and clinicians often need to followup with a clinical interview. This session will introduce participants to a validated risk assessment method...

Analgesic Development

Less than 10% of the analgesics in clinical trials make it past phase II studies. There are many reasons for this, including the inability of animal models to predict efficacy in humans and the placebo response with analgesic trials. This presentation will cover the preclinical models used to study...

Psychological Treatment for Chronic Pain: What Does the Evidence Say

Abundant evidence demonstrates the important contributions of psychological factors to chronic pain. These findings suggest that psychological treatments should be an important component of chronic pain management. This presentation will discuss common psychological approaches to pain management...

Evaluating Opioid Therapy for Non-Cancer Pain

Dr. Passik comments on the debate over opioids as appropriate for chronic non-cancer pain, identifying some shortcomings in the arguments from both sides.

Developing a Primary Care Disease Management Program

Dr. Herndon shares insights from the implementation of a chronic pain management program within a large family medicine program.

Chronic Pain and Neuromuscular Disease

Studies indicate that various neuromuscular disorders are often accompanied by chronic pain. Dr Carter discusses this relationship and some options for treatment that are available.